Patient NAME :Mrs.
YASMEEN Barcode : 10415276
ITDOSE INFOSYSTEMS PVT. LTD.
Age/Gender : 58 Y/Female Sample Registered ON : 16/Sep/2025 12:44PM
Lab NO : 012509160120 Sample Collected ON : 16/Sep/2025 12:45PM
UHID : 382021 Report Generated ON : 16/Sep/2025 05:12PM
Referred BY : SELF Report Approved ON : 16/Sep/2025 05:12PM
Panel NAME : CC1 Visit Type :
Test Result Unit Biological Reference Interval
DEPARTMENT OF HAEMATOLOGY
Glycosylated Hb (HbA1C) 8.3 % 4.0 - 5.6
Method:HPLC
Estimated Average Glucose (eAG) 191.51 mg/dL <126
Method:Calculated
INTERPRETATION :
As Per American Diabetes Association (ADA)
Reference Group HbA1c in %
Non diabetic adults ≥ 18 years 4.0 - 5.6
Prediabetes (At Risk) 5.7 to 6.4
Diabetes ≥ 6.5
Adults :
‡Goal of therapy : < 7.0
†Action suggested : > 8.0
Therapeutic goals for glycemic controls Pediatric Patients :
#Toddlers & Preschoolers : 7.5 - < 8.5
#6-12 years : < 8.0
#13-19 years : <7.5
†High risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiopathy. Action suggested
depends on individual patient circumstances.
‡Some danger of hypoglycemic reaction in type I diabetics. Some glucose intolerant (IGT) individuals and" Sub-Clinical" diabetics may
demonstrate (elevated ) HbA1 C in this area.
BIOCHEMISTRY
Blood Sugar Fasting 142 mg/dl 60.0 - 110.0
Method:GOD/POD
Blood Sugar (PP) 256 mg/dl 100.0- 150.0
Method:GOD/POD
*** End Of Report ***
Page 1 of 1
